HEC585

Idiopathic Pulmonary Fibrosis

Clinical trials

Developer

Sunshine Lake Pharma Co., Ltd.

Overview

HEC585 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 4 tracked IPF clinical trials.

HEC585 clinical trials

NCT03092102 (Phase 1)NCT05060822 (Phase 2)NCT05383131 (Phase 1)NCT04512170 (Phase 1)

Explore related

All trials Research

Medical disclaimer. This page summarizes research about HEC585 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.